AlzChem Group AG
ACTGermany
29 filed reports · 219 financial concepts · 3 earnings calls · 0 media appearances
Filed reports
29 reports · Mar 2018 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Q1Bundesanzeiger | 9 | 373 | Mar 2018 to Mar 2026 |
| Half YearBundesanzeiger | 8 | 1,222 | Jun 2019 to Jun 2026 |
| Q3Bundesanzeiger | 7 | 384 | Sep 2019 to Sep 2025 |
| AnnualBundesanzeiger | 5 | 247 | Dec 2021 to Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | half year | Jun 30, 2026 | Jun 30, 2026 | 138 | Open |
| FY2026 Q1 | q1 | Mar 31, 2026 | Mar 31, 2026 | 44 | Open |
| FY2025 | annual | Dec 31, 2025 | Dec 31, 2025 | 24 | Open |
| FY2025 Q3 | q3 | Sep 30, 2025 | Sep 30, 2025 | 62 | Open |
| FY2025 Q2 | half year | Jun 30, 2025 | Jun 30, 2025 | 129 | Open |
| FY2025 Q1 | q1 | Mar 31, 2025 | Mar 31, 2025 | 38 | Open |
| FY2024 | annual | Dec 31, 2024 | Dec 31, 2024 | 63 | Open |
| FY2024 Q3 | q3 | Sep 30, 2024 | Sep 30, 2024 | 58 | Open |
| FY2024 Q2 | half year | Jun 30, 2024 | Jun 30, 2024 | 140 | Open |
| FY2024 Q1 | q1 | Mar 31, 2024 | Mar 31, 2024 | 39 | Open |
| FY2023 | annual | Dec 31, 2023 | Dec 31, 2023 | 54 | Open |
| FY2023 Q3 | q3 | Sep 30, 2023 | Sep 30, 2023 | 60 | Open |
Financial data
219 concepts · 2,226 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
IFRS200 concepts · 2,042 facts · Jan 2018 to Jun 2026
- Total Assets46 · Mar 2018 to Jun 2026
- EBIT41 · Mar 2018 to Jun 2026
- Other interest and similar income41 · Mar 2018 to Jun 2026
- Interest Expense40 · Mar 2018 to Jun 2026
- Result from ordinary business activities40 · Mar 2018 to Jun 2026
- Cost of materials39 · Mar 2018 to Jun 2026
- Other operating expenses39 · Mar 2018 to Jun 2026
- Other operating income39 · Mar 2018 to Jun 2026
- Personnel expenses39 · Mar 2018 to Jun 2026
- thereof non-controlling interests39 · Mar 2018 to Jun 2026
- Income Tax Expense (Benefit)37 · Mar 2018 to Jun 2026
- Stockholders Equity37 · Mar 2018 to Jun 2026
- Revenue36 · Sep 2018 to Mar 2026
- Consolidated result for the period35 · Mar 2018 to Jun 2026
- Depreciation & Amortization35 · Sep 2019 to Jun 2026
- Other receivables and other assets33 · Mar 2018 to Jun 2026
- Total Current Liabilities31 · Mar 2018 to Jun 2026
- Inventory29 · Mar 2018 to Jun 2026
- Cash and Equivalents28 · Mar 2018 to Jun 2026
- Deferred taxes28 · Jun 2019 to Jun 2025
- Intangible Assets (excluding Goodwill)28 · Mar 2018 to Jun 2026
- Total Current Assets28 · Mar 2018 to Jun 2026
- Accounts Receivable, Net27 · Mar 2018 to Jun 2026
- Change in inventories of finished and unfinished products26 · Mar 2021 to Sep 2025
Segment13 concepts · 147 facts · Jun 2019 to Jun 2026
- External sales37 · Jun 2019 to Jun 2026
- EBITDA34 · Jun 2019 to Jun 2026
- Inventory24 · Jun 2019 to Jun 2025
- EBITDA margin12 · Jun 2021 to Jun 2026
- Product sales in the Specialty Chemicals segment12 · Jun 2020 to Jun 2026
- EBIT8 · Jun 2019 to Jun 2020
- Service sales in the Other & Holding segment6 · Jun 2019 to Jun 2026
- SPECIALTY CHEMICALS4 · Jun 2020 to Sep 2020
- Depreciation3 · Jun 2019
- Depreciation & Amortization3 · Jun 2020
- Interest income in the Specialty Chemicals segment2 · Jun 2026
- BASICS & INTERMEDIATES1 · Jun 2020
- OTHER & HOLDING1 · Jun 2020
KPI6 concepts · 37 facts · Mar 2021 to Dec 2025
- Discount rate17 · Mar 2021 to Mar 2025
- EBITDA margin9 · Sep 2021 to Dec 2025
- equity ratio4 · Sep 2021 to Sep 2024
- Discount rate3 · Jun 2021 to Jun 2024
- Extended cost of materials ratio3 · Sep 2023 to Sep 2025
- Equity ratio1 · Dec 2025
Segments
147 factsFigures broken down by business line, region, product or another axis the company reports on.
Operating segment4 members · 147 facts
- Other & Holding51 · Jun 2019 to Jun 2026
- Specialty Chemicals47 · Jun 2019 to Jun 2026
- Basics & Intermediates33 · Jun 2019 to Jun 2026
- Consolidation16 · Jun 2019 to Jun 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
3 calls · Oct 2025 to Jul 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Jul 30, 2026
- FY2025 Q4Feb 27, 2026
- FY2025 Q3Oct 30, 2025
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.